This inventor holds 2 USPTO granted patents. Top assignee: Glycotech Corp.. Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2001
Title: Eric G Bremer: Innovator in Pharmaceutical Compositions
Introduction
Eric G Bremer is a notable inventor based in Western Springs, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancers associated with epidermal growth factor (EGF) receptors. With a total of 2 patents, his work has the potential to impact cancer treatment methodologies.
Latest Patents
Eric's latest patents focus on pharmaceutical compositions for the treatment of EGF receptor-associated cancers. The inventions disclose carbohydrates and carbohydrate analogs that bind to EGF receptors. These methods are designed for various applications related to the EGF receptor, particularly in killing or inhibiting the growth of tumor cells with increased EGF receptor activity. This innovative approach could lead to more effective cancer therapies.
Career Highlights
Eric G Bremer is associated with Glycotech Corp., where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work emphasizes the importance of targeted therapies in treating complex diseases like cancer.
Collaborations
Eric collaborates with John L Magnani, leveraging their combined expertise to advance research and development in their field.
Conclusion
Eric G Bremer's contributions to pharmaceutical innovations highlight the critical role of targeted therapies in cancer treatment. His patents represent a significant step forward in the fight against EGF receptor-associated cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile